Tuesday, July 06, 2021 5:38:26 AM
Recent CLSD News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:10:09 PM
- Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema • GlobeNewswire Inc. • 11/07/2024 02:05:00 PM
- Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference • GlobeNewswire Inc. • 11/06/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:15:04 PM
- Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors • GlobeNewswire Inc. • 11/04/2024 12:05:00 PM
- Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024 • GlobeNewswire Inc. • 10/31/2024 11:05:00 AM
- Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting • GlobeNewswire Inc. • 10/22/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 11:55:13 AM
- Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes • GlobeNewswire Inc. • 10/09/2024 10:30:00 AM
- Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD • GlobeNewswire Inc. • 08/27/2024 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:15:08 PM
- Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • GlobeNewswire Inc. • 08/08/2024 11:05:00 AM
- Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024 • GlobeNewswire Inc. • 08/01/2024 11:05:00 AM
- Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 11:55:18 AM
- Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET • GlobeNewswire Inc. • 07/22/2024 04:00:00 PM
- Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board • GlobeNewswire Inc. • 07/11/2024 11:05:00 AM
- Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery • GlobeNewswire Inc. • 06/27/2024 11:05:00 AM
- Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting • GlobeNewswire Inc. • 06/12/2024 11:05:00 AM
- Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® • GlobeNewswire Inc. • 05/21/2024 11:05:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/10/2024 08:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:10:43 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM